tiprankstipranks
Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market

Unicycive Therapeutics (UNCY) Income Statement

Compare
431 Followers

Unicycive Therapeutics Income Statement

Last quarter (Q3 2024), Unicycive Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Unicycive Therapeutics's net income was $-4.10M. See Unicycive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 675.00K$ 951.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 675.00K$ 944.00K$ -1.00K$ 0.00$ 0.00
Operating Expenses
$ 21.45M$ 19.00M$ 8.98M$ 2.02M$ 1.96M
Depreciation and Amortization
$ 284.00K$ 7.00K$ 1.00K$ 2.02M$ 1.96M
EBITDA
$ -30.18M$ -18.05M$ -8.98M$ 0.00$ -63.00K
Operating Income
$ -20.77M$ -18.05M$ -8.98M$ -2.02M$ -1.96M
Other Income/Expenses
$ -9.77M$ -6.00K$ -1.04M$ -244.00K$ -202.00K
Pretax Income
$ -30.54M$ -18.06M$ -10.02M$ -2.26M$ -2.17M
Net Income
$ -30.54M$ -18.06M$ -10.63M$ -2.51M$ -2.30M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.28$ -1.20$ -0.71$ -0.16$ -0.27
Diluted EPS
$ -1.28$ -1.20$ -0.71$ -0.16$ -0.27
Weighted Average Shares Outstanding
24.54M 15.06M 15.00M 15.25M 8.43M
Weighted Average Shares Outstanding (Diluted)
24.54M 15.06M 15.00M 15.25M 8.47M
Currency in USD

Unicycive Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis